“These findings are highly pertinent in a clinical setting," researchers explained. 

The alert comes with "negative implications," given heightened danger the company could seek a distressed debt exchange. 

To date, the company has raised $42 million to develop its transcatheter mitral valve repair system.

Yousif Ahmad, MD, spoke with Cardiovascular Business about the latest advances in IVL therapy, including new reimbursement changes for the technology. 

Early research suggests initiating therapy with senescence-inhibiting drugs could limit the risk of these side effects. 

Buzzworthy developments of the past few days.

For AI to achieve sweeping adoption across U.S. medicine, physicians will need to be assured they won’t be held liable should clinical algorithms make mistakes.

The administration announced Dec. 21 that it is granting providers extra time to submit claims disputes under the No Surprises Act. 

A new study found no significant differences in mortality based on race or ethnicity once cancer was confirmed.

Moving away from a score-based approach saved each radiologist from nearly 11 hours per year spent on such activities, experts wrote in Clinical Imaging.